General
| Peptide: | F2,5,12W |
| Microorganism: | Staphylococcus epidermidis |
| Administration: | |
| Stage: | Preformed biofilm |
| Notes: |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| Crystal violet assay | 51 - 90% | 20 uM | |
| Crystal violet assay | Not Active | 40 uM | |
| Resazurin assay | 51 - 90% | 10 uM | |
| Resazurin assay | > 90% | 40 uM | |
| Resazurin assay | 51 - 90% | 40 uM |
Reference
- E. Margo Molhoek, Albert van Dijk, Edwin J.A. Veldhuizen, Henk P. Haagsman, Floris J. Bikker A cathelicidin-2-derived peptide effectively impairs Staphylococcus epidermidis biofilms
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com